Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 4 (2007), Issue 3 (March)

1. Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells.
   Cancer Immunol Immunother, 56(5): 615-25. [Abstract] [Full-text]
2. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601).
   Expert Opin Drug Deliv, 4(2): 175-86. [Abstract] [Full-text]
3. Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain?
   Int J Radiat Oncol Biol Phys, 67(4): 1135-44. [Abstract] [Full-text]
4. Central neurocytoma: management recommendations based on a 35-year experience.
   Int J Radiat Oncol Biol Phys, 67(4): 1145-54. [Abstract] [Full-text]
5. Targeting malignant glioma survival signalling to improve clinical outcomes.
   J Clin Neurosci, 14(4): 301-8. [Abstract] [Full-text]
6. Occupational exposure to low frequency magnetic fields and the risk of low grade and high grade glioma.
   Cancer Causes Control, 18(3): 305-13. [Abstract] [Full-text]
7. Significance of cyclin D1 expression in meningiomas: a preliminary study.
   J Clin Neurosci, 14(4): 355-8. [Abstract] [Full-text]
8. Spinal drop metastasis of choroid plexus papilloma.
   J Clin Neurosci, 14(4): 381-3. [Abstract] [Full-text]
9. Expression and significance of glucocorticoid receptor alpha in meningiomas.
   J Clin Neurosci, 14(4): 359-63. [Abstract] [Full-text]
10. The interactions of aurein 1.2 with cancer cell membranes.
    Biophys Chem, 127(1): 78-83. [Abstract] [Full-text]
11. Spontaneous remission of a diffuse brainstem lesion in a neonate.
    Pediatr Radiol, 37(4): 399-402. [Abstract] [Full-text]
12. Molecular markers of extracellular matrix remodeling in glioblastoma vessels: microarray study of laser-captured glioblastoma vessels.
    Glia, 55(6): 559-72. [Abstract] [Full-text]
13. A paediatric supratentorial primitive neuroectodermal tumour associated with malignant astrocytic transformation and a clonal origin of both components.
    Neurosurg Rev, 30(2): 143-9; discussion 149. [Abstract] [Full-text]
14. CCM1 gene deletion identified by MLPA in cerebral cavernous malformation.
    Neurosurg Rev, 30(2): 155-9; discussion 159-60. [Abstract] [Full-text]
15. Inhibition of adenosine monophosphate-activated protein kinase induces apoptosis in multiple myeloma cells.
    Anticancer Drugs, 18(4): 405-10. [Abstract] [Full-text]
16. Delayed diagnosis of cerebellar hemangioblastoma after intracerebellar hemorrhage.
    Surg Neurol, 67(4): 419-21. [Abstract] [Full-text]
17. Surgery for mesencephalic cavernoma: case report.
    Surg Neurol, 67(4): 413-7; discussion 417-8. [Abstract] [Full-text]
18. Hiccup and neurosurgeons: a report of 4 rare dorsal medullary compressive pathologies and review of the literature.
    Surg Neurol, 67(4): 395-402; discussion 402. [Abstract] [Full-text]
19. Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme.
    Surg Neurol, 67(4): 388-91. [Abstract] [Full-text]
20. Recurrent responses to non-small cell lung cancer brain metastases with erlotinib.
    Lung Cancer, 56(1): 135-7. [Abstract] [Full-text]
21. Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients.
    Int J Cancer, 120(8): 1704-11. [Abstract] [Full-text]
22. Mobile phone use and risk of glioma in 5 North European countries.
    Int J Cancer, 120(8): 1769-75. [Abstract] [Full-text]
23. Does high-dose carmustine increase overall survival in supratentorial high-grade malignant glioma? An EBMT retrospective study.
    Int J Cancer, 120(8): 1782-6. [Abstract] [Full-text]
24. Malignant predominantly minigemistocytic glioma in two infants: a distinctive glioma variant?
    Neuropathol Appl Neurobiol, 33(2): 169-78. [Abstract] [Full-text]
25. The dose-volume interaction in adult supratentorial low-grade glioma: higher radiation dose is beneficial among patients with partial resection.
    J Neurooncol, 82(2): 165-70. [Abstract] [Full-text]
26. Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker.
    J Neurooncol, 82(2): 193-8. [Abstract] [Full-text]
27. Expression of VEGFR3 in glioma endothelium correlates with tumor grade.
    J Neurooncol, 82(2): 141-50. [Abstract] [Full-text]
28. Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors.
    J Neurooncol, 82(2): 177-81. [Abstract] [Full-text]
29. Screening for motility-associated genes in malignant astrocytoma cell lines.
    J Neurooncol, 82(2): 125-31. [Abstract] [Full-text]
30. Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme.
    J Neurooncol, 82(2): 133-9. [Abstract] [Full-text]
31. Oligodendroglioma with neurocytic differentiation versus atypical extraventricular neurocytoma: a case report of unusual pathologic findings of a spinal cord tumor.
    J Neurooncol, 82(2): 199-205. [Abstract] [Full-text]
32. Diffusion MRI in the early diagnosis of malignant glioma.
    J Neurooncol, 82(2): 221-5. [Abstract] [Full-text]
33. Lhermitte-Duclos disease.
    J Neurooncol, 82(2): 183-5. [Abstract] [Full-text]
34. A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma.
    J Neurooncol, 82(2): 207-9. [Abstract] [Full-text]
35. MRI findings of malignant transformation of epidermoid cyst: case report.
    J Neurooncol, 82(2): 171-4. [Abstract] [Full-text]
36. Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors.
    Cancer Res, 67(6): 2676-84. [Abstract] [Full-text]
37. Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1.
    Am J Clin Pathol, 127(4): 633-41. [Abstract] [Full-text]
38. Gains at the 1p36 chromosomal region are associated with symptomatic leptomeningeal dissemination of supratentorial glioblastomas.
    Am J Clin Pathol, 127(4): 585-90. [Abstract] [Full-text]
39. Volumetric assessment of tumor infiltration of adjacent white matter based on anatomic MRI and diffusion tensor tractography.
    Acad Radiol, 14(4): 431-6. [Abstract] [Full-text]
40. Cerebral lymphoma: clinical and radiological findings in 90 cases.
    Arch Iran Med, 10(2): 194-8. [Abstract] [Full-text]
41. 5-Aminolevulinic acid-based photodynamic therapy suppressed survival factors and activated proteases for apoptosis in human glioblastoma U87MG cells.
    Neurosci Lett, 415(3): 242-7. [Abstract] [Full-text]
42. Non-rigid alignment of pre-operative MRI, fMRI, and DT-MRI with intra-operative MRI for enhanced visualization and navigation in image-guided neurosurgery.
    Neuroimage, 35(2): 609-24. [Abstract] [Full-text]
43. Moyamoya following cranial irradiation for primary brain tumors in children.
    Neurology, 68(12): 932-8. [Abstract] [Full-text]
44. Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging.
    Magn Reson Imaging, 25(3): 303-10. [Abstract] [Full-text]
45. Dendritic cell-based active specific immunotherapy for malignant glioma.
    Expert Opin Biol Ther, 7(4): 439-48. [Abstract] [Full-text]
46. Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells.
    Oncogene, 26(13): 1840-51. [Abstract] [Full-text]
47. BNCT for recurrent intracranial meningeal tumours - case reports.
    Acta Neurol Scand, 115(4): 243-7. [Abstract] [Full-text]
48. A simplified laboratory validated assay for MGMT promoter hypermethylation analysis of glioma specimens from formalin-fixed paraffin-embedded tissue.
    Lab Invest, 87(4): 392-7. [Abstract] [Full-text]
49. Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model.
    Mol Cancer, 6: 22. [Abstract] [Full-text]
50. Glioma-associated endothelial cells show evidence of replicative senescence.
    Exp Cell Res, 313(6): 1192-202. [Abstract] [Full-text]
51. Multiple metastases of thyroid cancer in the cranium and pituitary gland in two dogs.
    J Small Anim Pract, 48(4): 237-9. [Abstract] [Full-text]
52. Insulin-like growth factor type I biology and targeting in malignant gliomas.
    Neuroscience, 145(3): 795-811. [Abstract] [Full-text]
53. Awake craniotomy versus surgery under general anesthesia for resection of intrinsic lesions of eloquent cortex--a prospective randomised study.
    Clin Neurol Neurosurg, 109(4): 335-43. [Abstract] [Full-text]
54. Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain.
    Gynecol Oncol, 105(1): 273-6. [Abstract] [Full-text]
55. Prefrontal cognitive dysfunction following brainstem lesion.
    Clin Neurol Neurosurg, 109(4): 379-82. [Abstract] [Full-text]
56. Preoperative imaging of superficially located glioma resection using short inversion-time inversion recovery images in high-field magnetic resonance imaging.
    Clin Neurol Neurosurg, 109(4): 327-34. [Abstract] [Full-text]
57. Desmoplastic infantile ganglioglioma/astrocytoma with cerebrospinal metastasis.
    J Clin Neurosci, 14(5): 498-501. [Abstract] [Full-text]
58. Foot drop: the first sign of an intracranial tumor?
    J Clin Neurosci, 14(5): 490-2. [Abstract] [Full-text]
59. Endoscopic endonasal pituitary surgery: surgical and outcome analysis of 50 cases.
    J Clin Neurosci, 14(5): 410-5. [Abstract] [Full-text]
60. Isolated intrasellar tuberculoma mimicking pituitary adenoma.
    J Clin Neurosci, 14(5): 477-81. [Abstract] [Full-text]
61. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
    J Neurosci Res, 85(5): 1033-45. [Abstract] [Full-text]
62. Turcot syndrome confirmed with molecular analysis.
    Eur J Neurol, 14(4): 470-2. [Abstract] [Full-text]
63. Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy.
    Eur J Neurol, 14(4): 391-8. [Abstract] [Full-text]
64. Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior.
    Brain Pathol, 17(2): 151-64. [Abstract] [Full-text]
65. Microsatellite instability in pediatric and adult high-grade gliomas.
    Brain Pathol, 17(2): 146-50. [Abstract] [Full-text]
66. Image fusion analysis of volumetric changes after interstitial low-dose-rate iodine-125 irradiation of supratentorial low-grade gliomas.
    Radiat Res, 167(4): 438-44. [Abstract] [Full-text]
67. MR and CT imaging of 24 pleomorphic xanthoastrocytomas (PXA) and a review of the literature.
    Neuroradiology, 49(4): 307-15. [Abstract] [Full-text]
68. Evaluation of pituitary macroadenomas with multidetector-row CT (MDCT): comparison with MR imaging.
    Neuroradiology, 49(4): 327-33. [Abstract] [Full-text]
69. Feasibility of contrast-enhanced sonography during resection of cerebral tumours: initial results of a prospective study.
    Ultrasound Med Biol, 33(4): 571-5. [Abstract] [Full-text]
70. Predicting outcome of patients with high-grade gliomas after radiotherapy using quantitative analysis of T1-weighted magnetic resonance imaging.
    Int J Radiat Oncol Biol Phys, 67(5): 1476-83. [Abstract] [Full-text]
71. Outcome after radiosurgery for brain metastases in patients with low Karnofsky performance scale (KPS) scores.
    Int J Radiat Oncol Biol Phys, 67(5): 1492-8. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.